{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T03:02:37Z","timestamp":1789614157077,"version":"build-2803163510"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:00:00Z","timestamp":1787356800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.breast.2026.104906","type":"journal-article","created":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:27:00Z","timestamp":1787495220000},"page":"104906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Oncotype DX-guided vs physician-directed chemotherapy and survival in HR+\/HER2- breast cancer"],"prefix":"10.1016","volume":"89","author":[{"given":"Jingkun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhao","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer K.","family":"Plichta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.breast.2026.104906_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"9814","key":"10.1016\/j.breast.2026.104906_bib2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","article-title":"Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials","volume":"379","author":"Peto","year":"2012","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.breast.2026.104906_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1804710","article-title":"Adjuvant chemotherapy guided by a 21-Gene expression assay in breast cancer","volume":"379","author":"Sparano","year":"2018","journal-title":"N Engl J Med"},{"issue":"16","key":"10.1016\/j.breast.2026.104906_bib4","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1200\/JCO.22.00069","article-title":"Biomarkers for adjuvant endocrine and chemotherapy in early-stage breast cancer: ASCO guideline update","volume":"40","author":"Andre","year":"2022","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2026.104906_bib5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1001\/jamaoncol.2015.43","article-title":"Initial trends in the use of the 21-Gene recurrence score assay for patients with breast cancer in the medicare population, 2005-2009","volume":"1","author":"Dinan","year":"2015","journal-title":"JAMA Oncol"},{"issue":"25","key":"10.1016\/j.breast.2026.104906_bib6","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1056\/NEJMoa2108873","article-title":"21-Gene assay to inform chemotherapy benefit in node-positive breast cancer","volume":"385","author":"Kalinsky","year":"2021","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.breast.2026.104906_bib7","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.amjsurg.2017.05.008","article-title":"Disparities in compliance with the oncotype DX breast cancer test in the United States: a national cancer data base assessment","volume":"215","author":"Kozick","year":"2018","journal-title":"Am J Surg"},{"issue":"3","key":"10.1016\/j.breast.2026.104906_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.5694\/mja12.11334","article-title":"The impact of a genomic assay (oncotype DX) on adjuvant treatment recommendations in early breast cancer","volume":"199","author":"de Boer","year":"2013","journal-title":"Med J Aust"},{"issue":"1","key":"10.1016\/j.breast.2026.104906_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41523-023-00559-6","article-title":"Oncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer","volume":"9","author":"Licata","year":"2023","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"10.1016\/j.breast.2026.104906_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10549-023-07227-0","article-title":"Real-world use of multigene signatures in early breast cancer: differences to clinical trials","volume":"205","author":"Licata","year":"2024","journal-title":"Breast Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.breast.2026.104906_bib11","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/1055-9965.EPI-23-1201","article-title":"Disparities in OncotypeDx testing and subsequent chemotherapy receipt by geography and socioeconomic status","volume":"33","author":"Van Alsten","year":"2024","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"1","key":"10.1016\/j.breast.2026.104906_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35525","article-title":"Comparison of incident breast cancer cases in the largest national US tumor registries","volume":"131","author":"Plichta","year":"2025","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.breast.2026.104906_bib13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/XCS.0000000000001214","article-title":"American College of surgeons cancer program annual report from 2021 participant user file","volume":"240","author":"Habermann","year":"2025","journal-title":"J Am Coll Surg"},{"issue":"1","key":"10.1016\/j.breast.2026.104906_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cger.2011.10.002","article-title":"Early breast cancer in the older woman","volume":"28","author":"VanderWalde","year":"2012","journal-title":"Clin Geriatr Med"},{"issue":"26","key":"10.1016\/j.breast.2026.104906_bib15","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1200\/JCO.23.00933","article-title":"Practical assessment and management of vulnerabilities in older patients receiving systemic cancer therapy: ASCO guideline update","volume":"41","author":"Dale","year":"2023","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.breast.2026.104906_bib16","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann Oncol"},{"issue":"6","key":"10.1016\/j.breast.2026.104906_bib17","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.clbc.2025.05.018","article-title":"Disparities in access to multigene testing in early-stage, HR-positive, HER2-negative, lymph node-negative breast cancer","volume":"25","author":"Herr\u00e1n","year":"2025","journal-title":"Clin Breast Cancer"},{"issue":"9","key":"10.1016\/j.breast.2026.104906_bib18","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1200\/JCO.22.02477","article-title":"Adjuvant chemotherapy in older women with early breast cancer","volume":"41","author":"Trapani","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2026.104906_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2024.103821","article-title":"Chemotherapy in older patients with early breast cancer","volume":"78","author":"Schmidt","year":"2024","journal-title":"Breast"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096097762600216X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096097762600216X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:29:46Z","timestamp":1789612186000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096097762600216X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":19,"alternative-id":["S096097762600216X"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2026.104906","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncotype DX-guided vs physician-directed chemotherapy and survival in HR+\/HER2- breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2026.104906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104906"}}